http://www.in-pharmatechnologist.com/ Breaking News on Pharmaceutical Technology en-gb ℗ & © 2009 Decision News Media fabien.scantamburlo@decisionnews.com (Fabien Scantamburlo) fabien.scantamburlo@decisionnews.com (Fabien Scantamburlo) Fri, 20 Nov 2009 22:13:38 +0100 eZ Components Feed 1.2.1 (http://ezcomponents.org/docs/tutorials/Feed) http://www.rssboard.org/rss-specification 60 http://www.in-pharmatechnologist.com/var/plain_site/storage/images/rss-feeds/in-pharmatechnologist-podcast/1263917-5-eng-GB/in-PharmaTechnologist-Podcast.gif http://www.in-pharmatechnologist.com/ Fabien Scantamburlo Clean fabien.scantamburlo@decisionnews.com Fabien Scantamburlo in-PharmaTechnologist Podcast Breaking News on Pharmaceutical Technology http://www.in-pharmatechnologist.com/Industry-Drivers/AAPS-trends-in-turbulent-times?utm_source=RSS_podcast AAPS 2009 has drawn to a close but over the three days numerous trends and debates emerged, including the strategies CROs are using in the downturn, and we take a look at these in our conference round up. nick.taylor@decisionnews.com http://www.in-pharmatechnologist.com/Industry-Drivers/AAPS-trends-in-turbulent-times?utm_source=RSS_podcast Thu, 12 Nov 2009 11:00:00 +0100 nick.taylor@decisionnews.com AAPS AAPS - trends in turbulent times AAPS 2009 has drawn to a close but over the three days numerous trends and debates emerged, including the strategies CROs are using in the downturn, and we take a look at these in our conference round up. http://www.in-pharmatechnologist.com/Industry-Drivers/AAPS-round-up-of-day-one?utm_source=RSS_podcast Following the first full day of AAPS 2009 in Los Angeles, California, US we take a look at the major developments and talking points. nick.taylor@decisionnews.com http://www.in-pharmatechnologist.com/Industry-Drivers/AAPS-round-up-of-day-one?utm_source=RSS_podcast Tue, 10 Nov 2009 11:00:00 +0100 nick.taylor@decisionnews.com AAPS AAPS - round up of day one Following the first full day of AAPS 2009 in Los Angeles, California, US we take a look at the major developments and talking points. http://www.in-pharmatechnologist.com/Industry-Drivers/OctoPlus-Glycotope-Merck-KGaA-and-SCM-Pharma-on-BioPh-2009?utm_source=RSS_podcast How successful was the BioPh conference in Madrid? in-PharmaTechnologist asked key players attending the inaugural event. gareth.macdonald@decisionnews.com http://www.in-pharmatechnologist.com/Industry-Drivers/OctoPlus-Glycotope-Merck-KGaA-and-SCM-Pharma-on-BioPh-2009?utm_source=RSS_podcast Thu, 29 Oct 2009 11:00:00 +0100 gareth.macdonald@decisionnews.com BioPh, P-Mec, Glycotope, CPhI, ICSE, biologics, biomanufacturing, small molecules, CMO, OctoPlus, Merck, SCM Pharma OctoPlus, Glycotope, Merck KGaA and SCM Pharma on BioPh 2009 How successful was the BioPh conference in Madrid? in-PharmaTechnologist asked key players attending the inaugural event. http://www.in-pharmatechnologist.com/Materials-Formulation/Cargill-discusses-Zerose-erythritol-s-development?utm_source=RSS_podcast Henry Hussell, marketing manager at Cargill Pharma, talks about Zerose erythritol's development since it was launched at CPhI 2008. nick.taylor@decisionnews.com http://www.in-pharmatechnologist.com/Materials-Formulation/Cargill-discusses-Zerose-erythritol-s-development?utm_source=RSS_podcast Mon, 19 Oct 2009 11:00:00 +0200 nick.taylor@decisionnews.com Cargill discusses Zerose erythritol's development Henry Hussell, marketing manager at Cargill Pharma, talks about Zerose erythritol's development since it was launched at CPhI 2008. http://www.in-pharmatechnologist.com/Materials-Formulation/CPhI-2009-Road-to-recovery?utm_source=RSS_podcast As CPhI 2009 draws to a close we take a look back on the show, which, despite some negatives, appears to have been an overall success. nick.taylor@decisionnews.com http://www.in-pharmatechnologist.com/Materials-Formulation/CPhI-2009-Road-to-recovery?utm_source=RSS_podcast Thu, 15 Oct 2009 11:00:00 +0200 nick.taylor@decisionnews.com CPhI CPhI 2009 - Road to recovery? As CPhI 2009 draws to a close we take a look back on the show, which, despite some negatives, appears to have been an overall success. http://www.in-pharmatechnologist.com/Industry-Drivers/Gene-therapy-to-drive-viral-and-biologics-market-says-SAFC?utm_source=RSS_podcast SAFC Pharma has added extra viral and biologics capacity at its California plant in a $12m project that allows it to take projects from the lab to commercial scale. gareth.macdonald@decisionnews.com http://www.in-pharmatechnologist.com/Industry-Drivers/Gene-therapy-to-drive-viral-and-biologics-market-says-SAFC?utm_source=RSS_podcast Wed, 14 Oct 2009 11:00:00 +0200 gareth.macdonald@decisionnews.com viral, SAFC Pharma, gene therapy, biologics Gene therapy to drive viral and biologics market, says SAFC SAFC Pharma has added extra viral and biologics capacity at its California plant in a $12m project that allows it to take projects from the lab to commercial scale. http://www.in-pharmatechnologist.com/Industry-Drivers/CPhI-2009-show-preview?utm_source=RSS_podcast We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies. nick.taylor@decisionnews.com http://www.in-pharmatechnologist.com/Industry-Drivers/CPhI-2009-show-preview?utm_source=RSS_podcast Thu, 08 Oct 2009 11:00:00 +0200 nick.taylor@decisionnews.com Madrid, CPhI CPhI 2009 show preview We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies. http://www.in-pharmatechnologist.com/Processing-QC/TFS-and-Siemens-hope-to-have-process-analysis-down-PAT?utm_source=RSS_podcast US group Thermo Fisher Scientific and industrial engineering giant Siemens have teamed up to offer the pharmaceutical industry a new way of assessing processes used during early drug development, manufacturing scale up and commercial production. gareth.macdonald@decisionnews.com http://www.in-pharmatechnologist.com/Processing-QC/TFS-and-Siemens-hope-to-have-process-analysis-down-PAT?utm_source=RSS_podcast Wed, 01 Jul 2009 11:00:00 +0200 gareth.macdonald@decisionnews.com process FT-NIR, Thermo Fisher Scientific, Siemens, Sipat TFS and Siemens hope to have process analysis down PAT US group Thermo Fisher Scientific and industrial engineering giant Siemens have teamed up to offer the pharmaceutical industry a new way of assessing processes used during early drug development, manufacturing scale up and commercial production. http://www.in-pharmatechnologist.com/Materials-Formulation/Symyx-launches-CDMO?utm_source=RSS_podcast At BIO 2009 Symyx was promoting its new CDMO offering, which it believes meets a “real need in the industry” and can save clients time and materials by leveraging its prior knowledge. nick.taylor@decisionnews.com http://www.in-pharmatechnologist.com/Materials-Formulation/Symyx-launches-CDMO?utm_source=RSS_podcast Wed, 03 Jun 2009 11:00:00 +0200 nick.taylor@decisionnews.com Symyx Symyx launches CDMO At BIO 2009 Symyx was promoting its new CDMO offering, which it believes meets a “real need in the industry” and can save clients time and materials by leveraging its prior knowledge. http://www.in-pharmatechnologist.com/Industry-Drivers/Meet-Our-New-Owners?utm_source=RSS_videocast Don’t miss this video interview with Robert Marr, chief operating officer of William Reed Business Media which recently acquired Decision News Media publisher of in-PharmaTechnologist. gareth.macdonald@decisionnews.com http://www.in-pharmatechnologist.com/Industry-Drivers/Meet-Our-New-Owners?utm_source=RSS_videocast Wed, 03 Jun 2009 11:00:00 +0200 gareth.macdonald@decisionnews.com Decision News Media, William Reed Business Media Meet Our New Owners Don’t miss this video interview with Robert Marr, chief operating officer of William Reed Business Media which recently acquired Decision News Media publisher of in-PharmaTechnologist.